Zhang, Xiaochun

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Rha, S. Y., Oh, D.-Y., Yañez, P., Bai, Y., Ryu, M.-H., Lee, J., Rivera, F., Alves, G. V., Garrido, M., Shiu, K.-K., et al. (2023) · The Lancet Oncology

Gastric Cancer Management and OutcomesCancer Immunotherapy and Biomarkers

Cited by 690

Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma

Pillarisetti, K., Powers, G., Luistro, L., Babich, A., Baldwin, E., Li, Y., Zhang, X., Mendonça, M., Majewski, N., Nanjunda, R., et al. (2020) · Blood Advances

Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 144

H3-OPT: Accurate prediction of CDR-H3 loop structures of antibodies with deep learning

Chen, H., Fan, X., Zhu, S., Pei, Y., Zhang, X., Zhang, X., Liu, L., Qian, F., & Tian, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory)

Protein Structure and DynamicsMonoclonal and Polyclonal Antibodies Research

Cited by 1